Dupixent Specified Drug Use Investigation for long term use (Asthma)
Not Applicable
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000036992
- Lead Sponsor
- Sanofi K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 391
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients who have been administered Dupixent in the past -Patients who are participating in or have been registered for clinical trials with therapeutic intervention of Dupixent -Patients with a history of hypersensitivity to the ingredients of Dupixent -Patients who are contraindicated in the package insert of Dupixent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety: Occurrence of cases of eosinophilia over 5000/micro L, and eosinophilia with clinical symptoms
- Secondary Outcome Measures
Name Time Method Safety: Occurrence of adverse drug reactions Effectiveness: Severe asthma exacerbation